Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Sigma-Aldrich Acquires Research Organics to Strengthen Portfolio of Pharmaceutical-Grade Raw Materials
7:37 AM MDT | April 5, 2012 | Deepti Ramesh
Sigma-Aldrich says it has acquired all outstanding shares of Research Organics (Cleveland, OH), to expand the company’s buffer production capacity and to increase its portfolio of pharma grade raw materials for the biopharmaceutical and diagnostic markets. Financial terms of the purchase were not disclosed. Research Organics is a leading supplier of high purity biochemicals for use in molecular biology, diagnostics, cell culture, pharmaceuticals, biopharmaceuticals, life sciences and biotechnology and will transition into Sigma-Aldrich Fine Chemicals...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee